THROMBOTIC MICROANGIOPATHY
Clinical trials for THROMBOTIC MICROANGIOPATHY explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC MICROANGIOPATHY trials appear
Sign up with your email to follow new studies for THROMBOTIC MICROANGIOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare Post-Transplant blood disorder?
Disease control CompletedThis study tested a drug called ravulizumab in 41 children who developed a serious blood clotting problem (thrombotic microangiopathy) after a stem cell transplant. The treatment was given for 26 weeks, and researchers checked if it helped improve blood counts and kidney function…
Matched conditions: THROMBOTIC MICROANGIOPATHY
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New hope for stem cell transplant patients facing deadly blood clot disorder
Disease control CompletedThis study tested a drug called ravulizumab in 148 people aged 12 and older who developed a serious blood clotting condition (thrombotic microangiopathy) after a stem cell transplant. The goal was to see if the drug could improve survival and prevent the condition from getting wo…
Matched conditions: THROMBOTIC MICROANGIOPATHY
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 06, 2026 16:13 UTC